CurePSP Uses Venture Grants to Fund Four Progressive Supranuclear Palsy Studies
MabelAmber / Pixabay

CurePSP Uses Venture Grants to Fund Four Progressive Supranuclear Palsy Studies

According to a story from Business Wire, the non-profit foundation CurePSP has agreed to allocate funding for four venture grants. The funding is worth over $300,000 and will be directed…

Continue Reading CurePSP Uses Venture Grants to Fund Four Progressive Supranuclear Palsy Studies
New Guidelines Cite the Need for Better Support for Complex Regional Pain Syndrome Patients
geralt / Pixabay

New Guidelines Cite the Need for Better Support for Complex Regional Pain Syndrome Patients

According to a story from the Royal College of Physicians, the organization has chosen to release new guidelines regarding the treatment of patients with complex regional pain syndrome, a potentially…

Continue Reading New Guidelines Cite the Need for Better Support for Complex Regional Pain Syndrome Patients
Can a Lethally Poisonous Mushroom Hold the Key to Beating Pancreatic Cancer?
Josch13 / Pixabay

Can a Lethally Poisonous Mushroom Hold the Key to Beating Pancreatic Cancer?

According to a story from the Vancouver Sun, an extremely poisonous mushroom appears to contain some compounds that could be potentially effective in fighting cancer cells. A 2012 study demonstrated…

Continue Reading Can a Lethally Poisonous Mushroom Hold the Key to Beating Pancreatic Cancer?
October 2018 is the Expected Date for Top-Line Results From a Phase 3 Trial of an Experimental Treatment for Charcot-Marie-Tooth Disease
mohamed_hassan / Pixabay

October 2018 is the Expected Date for Top-Line Results From a Phase 3 Trial of an Experimental Treatment for Charcot-Marie-Tooth Disease

An ongoing Phase 3 clinical trial program is investigating the drug PXT3003 as an experimental treatment for Charcot-Marie-Tooth disease type 1A in adults. Pharnext SA says that they expect to…

Continue Reading October 2018 is the Expected Date for Top-Line Results From a Phase 3 Trial of an Experimental Treatment for Charcot-Marie-Tooth Disease
The First Patient Has Been Enrolled in a Study for Sjögren-Larsson Syndrome
rawpixel / Pixabay

The First Patient Has Been Enrolled in a Study for Sjögren-Larsson Syndrome

The first patient has been enrolled onto a Phase 3 clinical trial investigating topical dermal reproxalap as a possible treatment for Sjögren-Larsson syndrome associated ichthyosis. The original article can be read…

Continue Reading The First Patient Has Been Enrolled in a Study for Sjögren-Larsson Syndrome
Close Menu